{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:50:10Z","timestamp":1760986210742,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1053\/j.akdh.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T03:23:17Z","timestamp":1693365797000},"page":"387-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Palliative Care in Kidney and Liver Diseases"],"prefix":"10.1053","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8663-1449","authenticated-orcid":false,"given":"Antonio","family":"Corona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8058-1842","authenticated-orcid":false,"given":"Serife","family":"Eti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.akdh.2023.07.003_bib1","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.cgh.2019.01.043","article-title":"Association between renal function pattern and mortality in patients with cirrhosis","volume":"17","author":"Cullaro","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"S1","key":"10.1053\/j.akdh.2023.07.003_bib2","first-page":"S122","article-title":"Dying with\u00a0end stage liver disease with cirrhosis: insights from Support. Study to understand Prognoses and Preferences for outcomes and risks of treatment","volume":"48","author":"Roth","year":"2000","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"10.1053\/j.akdh.2023.07.003_bib3","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1007\/s10620-019-05983-y","article-title":"Measuring the quality of palliative care for patients with end-stage liver disease","volume":"65","author":"Patel","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib4","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.akdh.2023.07.003_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"Journal of hepatology"},{"issue":"5","key":"10.1053\/j.akdh.2023.07.003_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064089","article-title":"Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation","volume":"8","author":"Romano","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.akdh.2023.07.003_bib8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4254\/wjh.v14.i2.420","article-title":"Modified EASL-CLIF criteria that is easier to use and perform better to prognosticate acute-on-chronic liver failure","volume":"14","author":"Thuluvath","year":"2022","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/cld.534","article-title":"Elevated creatinine in a patient with cirrhosis","volume":"7","author":"Klavan","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.akdh.2023.07.003_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/108139","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a Prospective cohort study","volume":"2015","author":"Allegretti","year":"2015","journal-title":"Int J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000355739","article-title":"Hepatorenal syndrome and novel advances in its management","volume":"37","author":"Fabrizi","year":"2013","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000371748","article-title":"Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study","volume":"41","author":"Srisawat","year":"2015","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/liv.13389","article-title":"Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications","volume":"37","author":"Staufer","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.34067\/KID.0006952020","article-title":"Patients with hepatorenal syndrome should Be Dialyzed? PRO","volume":"2","author":"Velez","year":"2020","journal-title":"Kidney360"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.clpt.2006.05.006","article-title":"Liver disease selectively modulates cytochrome P450--mediated metabolism","volume":"80","author":"Frye","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib17","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3748\/wjg.v22.i3.1260","article-title":"Pharmacokinetic drug interactions in liver disease: an update","volume":"22","author":"Palatini","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"10.1053\/j.akdh.2023.07.003_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/liv.13305","article-title":"Why and how to measure renal function in patients with liver disease","volume":"37","author":"Piano","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis","volume":"33","author":"Peng","year":"2019","journal-title":"Palliat Med"},{"issue":"10","key":"10.1053\/j.akdh.2023.07.003_bib20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/liv.12215","article-title":"Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use","volume":"33","author":"Rogal","year":"2013","journal-title":"Liver Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cld.737","article-title":"Risk of Nonsteroidal anti-inflammatory drugs and safety of acetaminophen in patients with advanced liver disease","volume":"12","author":"Malespin","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"12","key":"10.1053\/j.akdh.2023.07.003_bib22","first-page":"1138","article-title":"Comparison of tissue and plasma levels of ibuprofen after oral and topical administration","volume":"46","author":"Dominkus","year":"1996","journal-title":"Arzneim-Forsch"},{"issue":"5","key":"10.1053\/j.akdh.2023.07.003_bib23","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s10620-014-3453-3","article-title":"Fibromyalgia symptoms and cirrhosis","volume":"60","author":"Rogal","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cld.711","article-title":"Pain management in patients with cirrhosis","volume":"11","author":"Rakoski","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"12","key":"10.1053\/j.akdh.2023.07.003_bib25","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/antiox10121949","article-title":"Downregulation of glutathione-mediated detoxification capacity by Binge drinking aggravates acetaminophen-induced liver injury through IRE1\u03b1 ER stress Signaling","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants"},{"issue":"8","key":"10.1053\/j.akdh.2023.07.003_bib26","first-page":"34","article-title":"\u201cOpioid dosing in renal and hepatic impairment\u201d","volume":"39","author":"Gelot","year":"2014","journal-title":"US Pharm"},{"issue":"5","key":"10.1053\/j.akdh.2023.07.003_bib27","first-page":"708","article-title":"Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease","volume":"89","author":"Galati","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"949","key":"10.1053\/j.akdh.2023.07.003_bib28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","article-title":"Methadone: applied pharmacology and use as adjunctive treatment in chronic pain","volume":"80","author":"Brown","year":"2004","journal-title":"Postgrad Med J"},{"issue":"7","key":"10.1053\/j.akdh.2023.07.003_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1053\/j.akdh.2023.07.003_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients","volume":"28","author":"Dean","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"10.1053\/j.akdh.2023.07.003_bib31","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ckj\/sfx080","article-title":"2017 update on pain management in patients with chronic kidney disease","volume":"10","author":"Pham","year":"2017","journal-title":"Clin kidney J"},{"issue":"7","key":"10.1053\/j.akdh.2023.07.003_bib32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/FPC.0000000000000057","article-title":"PharmGKB summary: tramadol pathway","volume":"24","author":"Gong","year":"2014","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MNH.0000000000000646","article-title":"Pain management in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Roy","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/026921601669626431","article-title":"Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine","volume":"15","author":"Lee","year":"2001","journal-title":"Palliat Med"},{"issue":"9","key":"10.1053\/j.akdh.2023.07.003_bib35","first-page":"1072","article-title":"Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions","volume":"25","author":"Labroo","year":"1997","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0310057X0503300306","article-title":"Acute pain management pharmacology for the patient with concurrent renal or hepatic disease","volume":"33","author":"Murphy","year":"2005","journal-title":"Anaesth Intensive Care"},{"issue":"4","key":"10.1053\/j.akdh.2023.07.003_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5055\/jom.2012.0123","article-title":"High dose of buprenorphine in terminally ill patient with liver failure: efficacy and tolerability","volume":"8","author":"Ciccozzi","year":"2012","journal-title":"J Opioid Manag"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib38","article-title":"Guidelines on the management of ascites in cirrhosis","volume":"55","author":"Moore","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.akdh.2023.07.003_bib39","first-page":"103","article-title":"Palliative treatment of malignant ascites: profile of catumaxomab","volume":"4","author":"Ammouri","year":"2010","journal-title":"Biologics"},{"issue":"13","key":"10.1053\/j.akdh.2023.07.003_bib40","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3748\/wjg.v10.i13.1881","article-title":"Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis","volume":"10","author":"Jiang","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0034-1382790","article-title":"Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up","volume":"31","author":"Copelan","year":"2014","journal-title":"Semin Intervent Radiol"},{"issue":"e1","key":"10.1053\/j.akdh.2023.07.003_bib42","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1136\/flgastro-2022-102128","article-title":"Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document","volume":"13","author":"Macken","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"10.1053\/j.akdh.2023.07.003_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4680543","article-title":"The palliative management of refractory cirrhotic ascites using the PleurX (\u00a9) catheter","volume":"2016","author":"Reinglas","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/apt.15802","article-title":"Randomised clinical trial: palliative long-term abdominal drains versus large volume paracentesis in refractory ascites due to cirrhosis","volume":"52","author":"Macken","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"Journal of hepatology"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib46","first-page":"42","article-title":"Pathophysiology and prevention of paracentesis-induced circulatory dysfunction: a Concise review","volume":"8","author":"Kulkarni","year":"2020","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/074811899201046","article-title":"The dual process model of coping with bereavement: rationale and description","volume":"23","author":"Stroebe","year":"1999","journal-title":"Death Stud"},{"issue":"8","key":"10.1053\/j.akdh.2023.07.003_bib48","article-title":"Hepatic encephalopathy and treatment modalities: a review article","volume":"14","author":"Sharma","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/2050640617727179","article-title":"Benzodiazepines and risk for hepatic encephalopathy in patients with cirrhosis and ascites","volume":"6","author":"Gr\u00f8nb\u00e6k","year":"2018","journal-title":"United European Gastroenterol J"},{"issue":"Suppl 2","key":"10.1053\/j.akdh.2023.07.003_bib50","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1016_21","article-title":"Management of Psychiatric disorders in patients with chronic kidney diseases","volume":"64","author":"Dalal","year":"2022","journal-title":"Indian J Psychiatry"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4292\/wjgpt.v8.i1.26","article-title":"Psychotropic drugs and liver disease: a critical review of pharmacokinetics and liver toxicity","volume":"8","author":"Telles-Correia","year":"2017","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"11","key":"10.1053\/j.akdh.2023.07.003_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4254\/wjh.v12.i11.883","article-title":"Malnutrition in cirrhosis: more food for thought","volume":"12","author":"Chapman","year":"2020","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1053\/j.akdh.2023.07.003_bib53","first-page":"1597","article-title":"What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review","volume":"28","author":"Economos","year":"2020","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1053\/j.akdh.2023.07.003_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2021.09.025","article-title":"Uremic encephalopathy","volume":"101","author":"Rosner","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.07.003_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.31887\/DCNS.2012.14.2\/mshear","article-title":"Grief and mourning gone awry: pathway and course of complicated grief","volume":"14","author":"Shear","year":"2012","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"10.1053\/j.akdh.2023.07.003_bib56","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12912-021-00684-2","article-title":"A literature-based study of patient-centered care and communication in nurse-patient interactions: barriers, facilitators, and the way forward","volume":"20","author":"Kwame","year":"2021","journal-title":"BMC Nurs"},{"issue":"6","key":"10.1053\/j.akdh.2023.07.003_bib57","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jpainsymman.2015.07.014","article-title":"Benefit of early palliative care intervention in end-stage liver disease patients Awaiting liver transplantation","volume":"50","author":"Baumann","year":"2015","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"10.1053\/j.akdh.2023.07.003_bib58","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s10620-020-06168-8","article-title":"Underutilization of hospice in Inpatients with cirrhosis: the NACSELD experience","volume":"65","author":"O\u2019Leary","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1053\/j.akdh.2023.07.003_bib59","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.cgh.2019.03.022","article-title":"Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease","volume":"17","author":"Ufere","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1053\/j.akdh.2023.07.003_bib60","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/hep.29297","article-title":"Palliative care access for hospitalized patients with end-stage liver disease across the United States","volume":"66","author":"Rush","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.32378","article-title":"AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis","volume":"76","author":"Rogal","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1053\/j.akdh.2023.07.003_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamainternmed.2022.6390","article-title":"Breaking the link between enrollment in hospice and discontinuation of dialysis","volume":"183","author":"Romero","year":"2023","journal-title":"JAMA Intern Med"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:39:37Z","timestamp":1757432377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2949813923000654"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.07.003","relation":{},"ISSN":["2949-8139"],"issn-type":[{"type":"print","value":"2949-8139"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palliative Care in Kidney and Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}